Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Kyleena™ (levonorgestrel-releasing intrauterine system) – New drug approval
September 19, 2016 – Bayer announced the FDA approval of Kyleena (levonorgestrel-releasing intrauterine system) for the prevention of pregnancy for up to 5 years.